These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 2925890)

  • 1. Relative efficacy of the Sc-O, P-O, P-N, and Sc MMPI scales in differentiating brain-damaged, brain-damaged schizophrenic, schizophrenic, and somatoform disorders in an outpatient setting.
    Puente AE; Rodenbough J; Horton AM
    J Clin Psychol; 1989 Jan; 45(1):99-105. PubMed ID: 2925890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The schizophrenia-organicity (SC-O) and psychiatric-organic (P-O) MMPI scales: a review.
    Watson CG
    J Clin Psychol; 1984 Jul; 40(4):1008-23. PubMed ID: 6480835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discrimination of schizophrenics with and without nervous system damage using the Luria-Nebraska Neuropsychological Battery.
    Puente AE; Heidelberg-Sanders C; Lund NL
    Int J Neurosci; 1982 Feb; 16(1):59-62. PubMed ID: 7169277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the effectiveness of MMPI indices in the discrimination of brain-damaged and schizophrenic patients.
    Graca J; Hutzell RR; Gaffney JM; Whiddon M
    J Clin Psychol; 1984 Mar; 40(2):427-31. PubMed ID: 6725565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MMPI profiles of brain-damaged and schizophrenic subjects.
    Russell EW
    J Clin Psychol; 1977 Jan; 33(1):190-3. PubMed ID: 556745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for organicity in concrete vs. overinclusive thought-disordered schizophrenics.
    Craig RJ; Verinis JS
    J Clin Psychol; 1979 Oct; 35(4):696-702. PubMed ID: 511992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Watson and the Hovey MMPI scales: do they measure organicity or "functional" psychopathology?
    Ruff CF; Ayers JL; Templer DI
    J Clin Psychol; 1977 Jul; 33(3):732-4. PubMed ID: 893702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diagnosis of brain-damage by the MMPI: a comprehensive evaluation.
    Golden CJ; Sweet JJ; Osmon DC
    J Pers Assess; 1979 Apr; 43(2):138-42. PubMed ID: 438935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the schizophrenia-organicity scale with brain-damaged and non-brain-damaged schizophrenics.
    Halperin KM; Neuringer C; Davies PS; Goldstein G
    J Consult Clin Psychol; 1977 Oct; 45(5):949-50. PubMed ID: 903456
    [No Abstract]   [Full Text] [Related]  

  • 10. A process approach to the Bender-Gestalt test and its use in differentiating schizophrenic, brain-damaged, and medical patients.
    Mermelstein JJ
    J Clin Psychol; 1983 Mar; 39(2):173-82. PubMed ID: 6841616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Empirical evaluation of diagnostic rules for evaluation of Luria-Nebraska Neuropsychological Battery profiles of chronic schizophrenic, schizoaffective, and brain-damaged patients.
    Moses JA; Thompson LL; Cardellino JP; Johnson GL
    Int J Neurosci; 1983 Oct; 21(1-2):119-27. PubMed ID: 6671867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of brain-damage in schizophrenics as measured by the Whitaker Index of Schizophrenic Thinking and the Luria-Nebraska Neuropsychological Battery.
    Puente AE; Heidelberg-Sanders C; Lund N
    Percept Mot Skills; 1982 Apr; 54(2):495-9. PubMed ID: 7079075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MMPI-derived indicators of organic brain dysfunction.
    Sillitti J
    J Clin Psychol; 1982 Jul; 38(3):601-5. PubMed ID: 7107925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiating brain damage from schizophrenia: a further test of Russell's MMPI key.
    Trifiletti RJ
    J Clin Psychol; 1982 Jan; 38(1):39-44. PubMed ID: 7056872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Separation of brain-damaged from psychiatric patients with the combined use of an ability and a personality test: a validation study with a Puerto Rican population.
    Arsuaga EN; Higgins JC; Sifre PA
    J Clin Psychol; 1986 Mar; 42(2):328-31. PubMed ID: 3958205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between neuropsychological deficit and MMPI profile in chronic schizophrenics.
    Osmon DC; Golden CJ
    Int J Neurosci; 1981; 13(2-3):67-74. PubMed ID: 7239789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MMPI profiles among neuropsychology patients.
    Wooten AJ
    J Clin Psychol; 1983 May; 39(3):392-406. PubMed ID: 6874973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further evidence that concerns the validity of an MMPI key for separation of brain-damaged and schizophrenic patients.
    Ryan JJ; Souheaver GT
    J Clin Psychol; 1977 Jul; 33(3):753-4. PubMed ID: 893708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of a brain-damage vs. schizophrenia MMPI key.
    Russell EW
    J Clin Psychol; 1975 Oct; 31(4):659-61. PubMed ID: 1194419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation of schizophrenics with and without brain damage using the Whitaker Index of Schizophrenic Thinking.
    Puente AE; Sanders CH
    J Clin Psychol; 1981 Jul; 37(3):464-6. PubMed ID: 7263870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.